Immune-strengthening antitumor syrup
Dosage form: light orange liquid with a characteristic bitter-spicy odor.
Ingredients: stevia leaf, calendula flowers, knotweed herb, clove flower buds, aconite root, valerian and licorice, prickly comfrey fruits, Icelandic moss, organic selenium, hydroalcoholic or hydrochloric acid solution, etc.
Pharmacological properties and action:Danavit-SK is a unique active natural immune-strengthening agent with anti-inflammatory, radioprotective and antitumor properties.
The drug (in a special dosage) allows you to inhibit tumor growth by up to 70-80%, provide effective radiation-protective (in the range of values obtained before irradiation up to 5 Gray), anti-inflammatory, restorative, antiarrhythmic and tonic effects.
The method of prevention and complex treatment of cancer patients with the drug Danavit-SK consists of several stages.
First of all, it is necessary to pay special attention to the fact that it is the cytostatic (i.e. stopping division) effect on young cells, and not the carcinolytic (destroying tumor cells as a whole) characteristic of preparations containing aconite.
The use of Danavit-SK in the preoperative period allows you to “encapsulate” the tumor and thereby, if necessary, contribute to the successful implementation of the surgical operation.
In the postoperative period, during the period of rehabilitation of cancer patients, it is necessary to use Danavit-SK, on the one hand, to “consolidate” the effect of the drug as a means of stopping tumor growth and its metastasis, and on the other hand, as an immune-strengthening and radioprotective agent that makes it easier to overcome the consequences of radiation and chemotherapy.
Aconite alkaloids have powerful radioprotective properties. They are able to reduce the negative effects of radiation exposure.
The use of aconite root alkaloids contained in the drug Danavit-SK by stage 4 cancer patients can reduce:
• growth of metastases up to 90%, thereby prolonging their life;
• the intensity of the pain syndrome, which allows you to reduce the daily dose of narcotic analgesics, and sometimes completely cancel them and, in most cases, avoid starting to take them.
Indications for use:
The drug is recommended for use for the prevention and treatment of:
brain tumor
thyroid cancer
throat cancer
lung cancer
breast cancer
rectal cancer
uterine cancer
prostate cancer, as well as during the rehabilitation of cancer patients during and after chemotherapy and radiation therapy.....
Dosage and method of administration.
The use of Danavita SK-1 depends on the specific conditions and stages of complex treatment or prevention.
The dose of Danavit SK - 1 is calculated approximately for the average person weighing 70-80 kg.
After 1-2 courses, it is necessary to verify the effectiveness of the drug by objective monitoring (ultrasound, CT, MRI, x-ray, mammogram, etc.).
If there is a decrease in the tumor or at least its stabilization, then courses of treatment must be repeated until complete cure, followed by periodic prophylaxis.
The drug has a general strengthening and mild tonic effect, Danavit SK-1 is taken orally.
It is advisable to take the drug 15-20 minutes before meals or 1.5-2 hours after meals.
Take starting with one drop per 50-100 ml of water 3 times a day, adding 1 drop daily at each dose and reach 10 drops 3 times a day.
Take this dosage for 10 days.
Then go to reduce the dose, reducing 1 drop daily at each appointment and reach the original dose - 1 drop per day ("slide" scheme).
For children, the dose of Danavit SK-1 should be less than the average dose for an adult, depending on the age and weight of the child.
To prevent cancer, take 1 drop per 50-100 ml of water 3 times a day for 1 month.
Oncology patients in the preoperative period - according to the “slide” scheme, starting with 1 drop, increasing every day to 10 drops on 1 day, and then decreasing in the reverse order. Course for 19 days.
Oncology patients in the postoperative period and during the rehabilitation period during chemotherapy and radiation therapy - one drop 3 times a day, start taking it during chemotherapy or radiation therapy. Course for a month.
Oncology patients stage 4 - using the “slide” method, followed by repetition depending on the patient’s condition. In each case, the individual treatment regimen, course duration, as well as inter-course and intra-course breaks are determined by the doctor.
Side effects. In rare cases, digestive problems and skin rashes or itching may occur. Some more sensitive people may experience a feeling of slight anxiety and increased heart rate. If the side effects are not severe, you should reduce the dose of the medicine until they disappear.
Contraindications. Allergic reaction and individual intolerance. Not recommended for pregnant and lactating women, with gastric ulcers and erosive gastritis, with individual intolerance to the components of the drug.
